Latest News

May 3, 2012

Phase1 study produces 83% remission from combination approach. Much respected US based cancer research pioneer, Professor Joseph Scandura, Assistant Professor of Medicine at Weill Cornell Medical College in New York, is in Cork today to share the results of his clinical study to improve treatment of acute leukaemias and bone marrow cancers

Apr 2, 2012

Three members of Cork’s oncology team will go the distance to participate in the upcoming 26 mile Marathon De Paris on 15th April in memory of world renowned cancer research pioneer, the late Professor Gerry O’Sullivan.

Mar 23, 2012

The Board of Directors at Cork Cancer Research Centre is pleased to announce that Professor Brendan Buckley has agreed to act as Interim Director of the Centre, following the recent passing of the Centre’s founder, the much respected Professor Gerry O Sullivan.

Oct 27, 2011

Women who have been on the pill for 10 or more years cut their risk of ovarian cancer by about 45%.

Oct 10, 2010
The first clinical trial results of an endoscopic device, developed by CCRC, for the treatment of internal cancers are revealed at a seminar in Dublin today.
Sep 21, 2010
Nobel Laureate Dr. James Watson delivers Inaugural Cancer Lecture of Cork Cancer Research Centre.
Jun 21, 2010
 County Rivals Unite to Walk the Way for Cancer Research.
Jun 21, 2010
Dr. Mark Tangney of CCRC has won the Junior Chamber International’s ‘Most Outstanding Young Person of the Year’ award at their annual award ceremony in Limerick recently.
May 21, 2010
Top European Award’s First Trip to Ireland.
Nov 21, 2009
Top Honours for CCRC Researchers at Tenth Annual IJMS Dcotors Awards.
Oct 21, 2009
CCRC PhD student Lisa Crowley wins award for research at the Annual Meeting of the Haematology Association of Ireland.

WELCOME

Cork Cancer Research Centre investigates major issues in the development and treatment of cancer, through teams of university based scientists and collaborating clinicians at multiple teaching hospitals.  The centre researches both primary and secondary disease which has already led to multiple clinical trials.

Our main focus is the development of new treatments for cancer that do not currently respond to conventional therapies.

“The laboratory and clinical experience are very closely intertwined and I think that makes our research much more meaningful”.  Prof Gerry O’Sullivan


 
 

Contact Us: